627 related articles for article (PubMed ID: 9031758)
21. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Nishikibe M
Br J Pharmacol; 1994 Oct; 113(2):336-8. PubMed ID: 7834180
[TBL] [Abstract][Full Text] [Related]
22. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
[TBL] [Abstract][Full Text] [Related]
23. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
Hay DW; Luttmann MA
J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123.
Douglas SA; Vickery-Clark LM; Ohlstein EH
Br J Pharmacol; 1993 Feb; 108(2):418-21. PubMed ID: 8448593
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by endothelin-1 of cholinergic nerve-mediated acetylcholine release and contraction in sheep isolated trachea.
Henry PJ; Shen A; Mitchelson F; Goldie RG
Br J Pharmacol; 1996 Jun; 118(3):762-8. PubMed ID: 8762105
[TBL] [Abstract][Full Text] [Related]
26. Endothelin receptor-mediated Ca2+ mobilization and contraction in bovine oviductal arteries: comparison with noradrenaline and potassium.
Labadía A; Costa G; Jimenez E; Triguero D; García-Pascual A
Gen Pharmacol; 1997 Oct; 29(4):611-9. PubMed ID: 9352311
[TBL] [Abstract][Full Text] [Related]
27. Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.
Iwasaki T; Hayasaki-Kajiwara Y; Shimamura T; Naya N; Nakajima M
Eur J Pharmacol; 2000 Jul; 400(2-3):255-62. PubMed ID: 10988342
[TBL] [Abstract][Full Text] [Related]
28. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
29. Influence of parainfluenza-1 respiratory tract viral infection on endothelin receptor-effector systems in mouse and rat tracheal smooth muscle.
Knott PG; Henry PJ; McWilliam AS; Rigby PJ; Fernandes LB; Goldie RG
Br J Pharmacol; 1996 Sep; 119(2):291-8. PubMed ID: 8886411
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.
Devadason PS; Henry PJ
Br J Pharmacol; 1997 May; 121(2):253-63. PubMed ID: 9154335
[TBL] [Abstract][Full Text] [Related]
31. Constriction of mouse hepatic venules and sinusoids by endothelins through ETB receptor subtype.
Ito Y; Katori M; Majima M; Kakita A
Int J Microcirc Clin Exp; 1996; 16(5):250-8. PubMed ID: 8951523
[TBL] [Abstract][Full Text] [Related]
32. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
Maguire JJ; Davenport AP
Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976
[TBL] [Abstract][Full Text] [Related]
33. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
34. Endothelin receptor mediating contraction of isolated bovine coronary artery.
Ishiguro S; Kawase J; Miyamoto A; Nishio A
J Vet Pharmacol Ther; 2001 Jun; 24(3):203-8. PubMed ID: 11442799
[TBL] [Abstract][Full Text] [Related]
35. Influence of respiratory tract viral infection on endothelin-1-induced potentiation of cholinergic nerve-mediated contraction in mouse trachea.
Carr MJ; Goldie RG; Henry PJ
Br J Pharmacol; 1996 Nov; 119(5):891-8. PubMed ID: 8922737
[TBL] [Abstract][Full Text] [Related]
36. Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
Ohlstein EH; Beck GR; Douglas SA; Nambi P; Lago MA; Gleason JG; Ruffolo RR; Feuerstein G; Elliott JD
J Pharmacol Exp Ther; 1994 Nov; 271(2):762-8. PubMed ID: 7965794
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of endothelin-induced contraction in the guinea-pig oesophageal muscularis mucosae.
Uchida K; Yuzuki R; Kamikawa Y
Br J Pharmacol; 1998 Oct; 125(4):849-57. PubMed ID: 9831924
[TBL] [Abstract][Full Text] [Related]
38. Characterization of endothelin receptor subtypes mediating Ca2+ mobilization and contractile response in rabbit iris dilator muscle.
Satoh M; Yamamoto Y; Takayanagi I
Br J Pharmacol; 1996 Mar; 117(6):1277-85. PubMed ID: 8882626
[TBL] [Abstract][Full Text] [Related]
39. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Miyauchi T; Ishikawa S; Onizuka M; Goto K; Nishikibe M
Br J Pharmacol; 1996 Mar; 117(6):995-9. PubMed ID: 8882588
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
Cirino M; Martin E; Yano M; Rodger IW
J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
